Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada ...Middle East

PR Newswire - News
Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene and betamethasone dipropionate) in Canada through Endo's subsidiary Paladin...

Hence then, the article about endo announces agreement for paladin pharma to commercialize wynzora cream in canada was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada )

Apple Storegoogle play

Last updated :

Also on site :